fbpx
Tuesday, October 4, 2022
Home Tags Boehringer Ingelheim

Tag: Boehringer Ingelheim

Boehringer Ingelheim launches initiative to promote heart health among women of...

The company noted Black and Latina women were "less likely to be admitted to specialized cardiology units."

Boehringer Ingelheim acquires oncology research firm Abexxa Biologics

Abexxa’s expertise involves targeting cancer-specific proteins located inside the cell.

Exclusive: Boehringer Ingelheim USA President/CEO Jean-Michel Boers on firm’s 50th anniversary,...

“The speed at which the industry was able to offer highly efficacious vaccinations is quite extraordinary,” Boers marvels. “It shows how important it is to invest in health care in the U.S.”

Boehringer Ingelheim exec acquires team that will play cricket for White...

The nascent league is scheduled to kick off its season on Sept. 3.

Boehringer Ingelheim teams with Yale on biomedical fellowship program

Applications for the first cohort are being accepted through June 15.

Junk ‘king’ honored for pandemic-era altruism

McCabe is planning to be "more involved with community engagement-type events."

Leading regional companies lend their support for Equality Act passage

President Biden called for the legislation to be passed in his address to Congress this week.

Boehringer Ingelheim makes record investment in R&D during pandemic

The 2020 number is the highest annual investment in R&D in the pharma giant's 136-year history.

Danbury Mayor Boughton named state DRS commissioner; Delivers farewell address

Mark Boughton, who is in the midst of his record 10th term as the city’s mayor, will begin his new job on Dec. 18.

Boehringer Ingelheim appoints Yew Looi Liew as U.S. Human Pharma president

Liew, who succeeds Jean-Michel Boers, will be responsible for developing BI’s current human pharma portfolio and preparing the organization for future launches.

FDA gives fast track designation to test Jardiance for heart attack...

Test trial results are expected by 2023.

Jean-Michel Boers succeeding Wolfgang Baiker as head of Boehringer Ingelheim U.S.

Boers joined Boehringer Ingelheim in 1998 in Belgium, and came to the U.S. in 2016 as senior vice president of the Specialty Care Franchise; he has led the U.S. Human Pharma business since January 2017.

Ridgefield’s Boehringer Ingelheim launches Global Support Program to fight COVID-19

Among its efforts, Boehringer has made available $6.4 million for financial and in-kind donations for local emergency aid across its markets.

Taking a toll on commuters: Lamont woos politicians and residents on...

The future of the governos’s ambitious 10-year, $21 billion CT2030 plan is very much in doubt, with state Republicans remaining skeptical and several of his fellow Democratic lawmakers hedging their bets as next year’s election looms.

Boehringer Ingelheim, Sanofi targeted in class-action suit over Zantac

According to the lawsuit, “Zantac’s unprecedented sales were possible only because of a deception perpetrated by the drug’s manufacturers on consumers.”
: